Minerva Neurosciences, Inc.
News
(2)April 2026
Minerva Neurosciences Annual Report Highlights Cash Runway and Clinical Pipeline
# 🧾 What This Document Is This is Minerva Neurosciences' Annual Report to Shareholders (ARS). Think of it as the company's comprehensive "year in review" document, sent to all its owners (shareholders). It goes beyond the basic financial numbers to explain the business strategy, highlight major ac
Minerva Neurosciences, Inc. — 8-K Filing
# 🧾 What This Document Is This is a **Form 8-K filing**, which companies use to announce major events to investors. This particular filing has three attached exhibits that together tell one complete story: the departure of Minerva's President, Geoff Race, and the hiring of his replacement. The docu
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.